Drug Controller General
-
{
- All
- News
- Videos
-
Oncologists Explain Why They Prescribe Keytruda To Cancer Patients, When And How It Works
- Tuesday April 14, 2026
- Health | Written by Debosmita Ghosh
Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
www.ndtv.com
-
What Is Keytruda And Why Is Everyone Talking About It In India's Cancer Fight?
- Monday April 13, 2026
- Health | Written by Debosmita Ghosh
In India, Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
www.ndtv.com
-
Can Using Birth Control Pills Cause Infertility? Fertility Doctor Answers Common Query Women Have
- Wednesday February 11, 2026
- Health | Written by Shreya Goswami
Reversible contraceptives like birth control pills, patches, IUDs and implants do not cause permanent infertility for most women. Fertility generally returns within months after stopping use, though some methods may cause short delays.
-
www.ndtv.com
-
After Pharma Firm's Huge Eye Drop Claim, Regulator Withdraws Permission
- Wednesday September 11, 2024
- India News | Edited by Debanish Achom
Taking serious note of Mumbai-based Entod Pharmaceuticals' claims that it can help reduce dependency on reading glasses for those suffering from presbyopia, the Drugs Controller General of India (DGCI) has suspended permission given to the company.
-
www.ndtv.com
-
All About PresVu, New Eye Drops That Can Remove Reading Glasses In 15 Mins
- Thursday September 5, 2024
- India News | Edited by NDTV News Desk
The Drugs Controller General of India has approved Entod Pharmaceuticals' PresVu eye drops, which is said to be a breakthrough in the treatment of presbyopia.
-
www.ndtv.com
-
Only Processing Charges To Be Levied For Procuring Blood At Hospitals, Blood Banks: Drug Regulator
- Friday January 5, 2024
- India News | Press Trust of India
Hospitals and blood banks can now only charge processing fees for blood as the apex drug regulator has decided to do away with all other fees to check the practice of overcharging.
-
www.ndtv.com
-
Sale Of False Version Of 2 Drugs To Be Monitored In India After WHO Alert
- Monday September 11, 2023
- India News | Press Trust of India
The Drugs Controller General of India has directed the drugs controllers of all states and Union territories to keep a strict vigil on the sale and distribution of falsified versions of two drugs.
-
www.ndtv.com
-
Gennova mRNA Covid Booster Vaccine Gets Emergency Use Authorisation
- Tuesday June 20, 2023
- India News | Press Trust of India
Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.
-
www.ndtv.com
-
Drugs Regulator Says Will Prioritise Making Regulation System Simpler
- Thursday May 11, 2023
- India News | Press Trust of India
Drugs Controller General of India (DCGI) Rajeev Singh Raghuvanshi on Thursday said bringing down regulatory intervention in the system and making it simpler is a top priority for the organisation.
-
www.ndtv.com
-
AstraZeneca Pharma's Cancer-Treating Drug Gets Regulator's Nod In India
- Wednesday May 3, 2023
- India News | Press Trust of India
AstraZeneca Pharma India Ltd on Wednesday said it has received an approval from the Drug Controller General of India (DCGI) for the cancer drug trastuzumab deruxtecan for treatment of metastatic breast cancer.
-
www.ndtv.com
-
Oncologists Explain Why They Prescribe Keytruda To Cancer Patients, When And How It Works
- Tuesday April 14, 2026
- Health | Written by Debosmita Ghosh
Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
www.ndtv.com
-
What Is Keytruda And Why Is Everyone Talking About It In India's Cancer Fight?
- Monday April 13, 2026
- Health | Written by Debosmita Ghosh
In India, Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
www.ndtv.com
-
Can Using Birth Control Pills Cause Infertility? Fertility Doctor Answers Common Query Women Have
- Wednesday February 11, 2026
- Health | Written by Shreya Goswami
Reversible contraceptives like birth control pills, patches, IUDs and implants do not cause permanent infertility for most women. Fertility generally returns within months after stopping use, though some methods may cause short delays.
-
www.ndtv.com
-
After Pharma Firm's Huge Eye Drop Claim, Regulator Withdraws Permission
- Wednesday September 11, 2024
- India News | Edited by Debanish Achom
Taking serious note of Mumbai-based Entod Pharmaceuticals' claims that it can help reduce dependency on reading glasses for those suffering from presbyopia, the Drugs Controller General of India (DGCI) has suspended permission given to the company.
-
www.ndtv.com
-
All About PresVu, New Eye Drops That Can Remove Reading Glasses In 15 Mins
- Thursday September 5, 2024
- India News | Edited by NDTV News Desk
The Drugs Controller General of India has approved Entod Pharmaceuticals' PresVu eye drops, which is said to be a breakthrough in the treatment of presbyopia.
-
www.ndtv.com
-
Only Processing Charges To Be Levied For Procuring Blood At Hospitals, Blood Banks: Drug Regulator
- Friday January 5, 2024
- India News | Press Trust of India
Hospitals and blood banks can now only charge processing fees for blood as the apex drug regulator has decided to do away with all other fees to check the practice of overcharging.
-
www.ndtv.com
-
Sale Of False Version Of 2 Drugs To Be Monitored In India After WHO Alert
- Monday September 11, 2023
- India News | Press Trust of India
The Drugs Controller General of India has directed the drugs controllers of all states and Union territories to keep a strict vigil on the sale and distribution of falsified versions of two drugs.
-
www.ndtv.com
-
Gennova mRNA Covid Booster Vaccine Gets Emergency Use Authorisation
- Tuesday June 20, 2023
- India News | Press Trust of India
Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.
-
www.ndtv.com
-
Drugs Regulator Says Will Prioritise Making Regulation System Simpler
- Thursday May 11, 2023
- India News | Press Trust of India
Drugs Controller General of India (DCGI) Rajeev Singh Raghuvanshi on Thursday said bringing down regulatory intervention in the system and making it simpler is a top priority for the organisation.
-
www.ndtv.com
-
AstraZeneca Pharma's Cancer-Treating Drug Gets Regulator's Nod In India
- Wednesday May 3, 2023
- India News | Press Trust of India
AstraZeneca Pharma India Ltd on Wednesday said it has received an approval from the Drug Controller General of India (DCGI) for the cancer drug trastuzumab deruxtecan for treatment of metastatic breast cancer.
-
www.ndtv.com